Zinc and Diabetes in Patients With Thalassemia: a Pilot Study

Completed · Not applicable

Conditions studied: Thalassemia

In brief

The primary aim of this study is to measure zinc status and related proteins in patients with Thalassemia who have or do not have diabetes. The secondary aim will be to explore the effect of zinc supplementation on glucose metabolism in patients with thalassemia.

Key facts

Study ID

NCT01772680

Run by

UCSF Benioff Children's Hospital Oakland

People needed

40

Starts

2012-11-01

Expected to finish

2015-05-01

Last updated by the study team

2020-11-24

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• patients diagnosed with transfusion dependent thalassemia
• > 12 years of age
• Exclusion Criteria (for both cross-sectional and interventional studies)
• patients who are pregnant
• patients who are on growth hormone therapy
• Exclusion criteria (for intervention study only)
• patients who currently have diabetes (therefore cannot have an oral glucose tolerance test)

Where it is running

• Children's Hospital & Research Center Oakland — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.